T1	DISO 92 115	Enfermedad de Parkinson
#1	AnnotatorNotes T1	C0030567; Parkinson Disease; Disease or Syndrome
T2	PROC 152 176	tomografía de positrones
T3	PROC 189 192	PET
#2	AnnotatorNotes T3	C0032743; Positron-Emission Tomography; Diagnostic Procedure
T4	CHEM 211 230	fármaco diagnóstico
#3	AnnotatorNotes T4	C0358514; Diagnostic agent; Indicator, Reagent, or Diagnostic Aid
T5	PROC 219 230	diagnóstico
#4	AnnotatorNotes T5	C0011900; Diagnosis; Diagnostic Procedure
T6	DISO 319 329	enfermedad
#5	AnnotatorNotes T6	C0012634; Disease; Disease or Syndrome
T7	PROC 352 362	Evaluación
#6	AnnotatorNotes T7	C1261322; Evaluation procedure; Health Care Activity
T8	PROC 416 437	estudio observacional
#7	AnnotatorNotes T8	C1518527; Observational Study; Research Activity
T9	DISO 515 538	enfermedad de Parkinson
#8	AnnotatorNotes T9	C0030567; Parkinson Disease; Disease or Syndrome
T10	PROC 589 598	protocolo
#9	AnnotatorNotes T10	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T11	DISO 619 653	enfermedad de Parkinson prodrómica
T12	PROC 748 751	PET
#10	AnnotatorNotes T12	C0032743; Positron-Emission Tomography; Diagnostic Procedure
T13	CHEM 777 785	trazador
#11	AnnotatorNotes T13	C0034551; Radioactive Tracers; Element, Ion, or Isotope · Indicator, Reagent, or Diagnostic Aid | C1522485; Tracer; Indicator, Reagent, or Diagnostic Aid
T14	PROC 790 793	PET
#12	AnnotatorNotes T14	C0032743; Positron-Emission Tomography; Diagnostic Procedure
T15	CHEM 823 834	excipientes
#13	AnnotatorNotes T15	C0015237; Pharmaceutical Excipient; Biomedical or Dental Material
T16	PROC 934 937	PET
#14	AnnotatorNotes T16	C0032743; Positron-Emission Tomography; Diagnostic Procedure
T17	CHEM 244 255	florbetaben
#15	AnnotatorNotes T17	C3817505; Florbetaben F 18 Intravenous Solution; Clinical Drug
T18	CHEM 367 384	[18F] florbetaben
#16	AnnotatorNotes T18	C3817505; Florbetaben F 18 Intravenous Solution; Clinical Drug
T19	CHEM 795 812	[18F] florbetaben
#17	AnnotatorNotes T19	C3817505; Florbetaben F 18 Intravenous Solution; Clinical Drug
T20	CHEM 942 959	[18F] florbetaben
#18	AnnotatorNotes T20	C3817505; Florbetaben F 18 Intravenous Solution; Clinical Drug
T21	PROC 849 885	consentimiento informado por escrito
#19	AnnotatorNotes T21	C0811741; Obtain informed written consent; Health Care Activity
T22	Date 13 17	2015
T23	LIVB 52 73	sujetos participantes
#20	AnnotatorNotes T23	C0681850; Study Subject; Group + C4554048; Study Participant; Population Group
T24	LIVB 81 88	cohorte
#21	AnnotatorNotes T24	C0599755; Cohort; Population Group
T25	Route 231 242	intravenoso
#22	AnnotatorNotes T25	C1522726; Intravenous Route of Drug Administration; Functional Concept
T26	LIVB 388 409	sujetos participantes
#23	AnnotatorNotes T26	C0681850; Study Subject; Group + C4554048; Study Participant; Population Group
T27	LIVB 565 572	Sujetos
#24	AnnotatorNotes T27	C0681850; Study Subject; Group
T28	LIVB 605 614	pacientes
#25	AnnotatorNotes T28	C0030705; Patients; Patient or Disabled Group
T29	Age 659 677	superior a 60 años
T30	Neg_cue 835 837	No
T31	PHYS 960 968	Embarazo
#26	AnnotatorNotes T31	C0032961; Pregnancy; Organism Function
T32	PHYS 971 980	lactancia
#27	AnnotatorNotes T32	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T33	DISO 752 764	Intolerancia
#28	AnnotatorNotes T33	C0277585; Intolerance to drug; Pathologic Function
A1	Assertion T21 Negated
A2	Assertion T12 Contraindicated
A3	Status T33 History_of
#29	AnnotatorNotes T2	C0032743; Positron-Emission Tomography; Diagnostic Procedure
R1	Experiences Arg1:T24 Arg2:T1	
R2	Experiences Arg1:T23 Arg2:T1	
R3	Experiences Arg1:T23 Arg2:T2	
R4	Experiences Arg1:T23 Arg2:T3	
R5	Experiences Arg1:T24 Arg2:T2	
R6	Experiences Arg1:T24 Arg2:T3	
R7	Experiences Arg1:T23 Arg2:T4	
R8	Experiences Arg1:T23 Arg2:T17	
R9	Experiences Arg1:T24 Arg2:T4	
R10	Experiences Arg1:T24 Arg2:T17	
R11	Has_Route_or_Mode Arg1:T4 Arg2:T25	
R12	Has_Route_or_Mode Arg1:T17 Arg2:T25	
R13	Used_for Arg1:T4 Arg2:T2	
R14	Used_for Arg1:T17 Arg2:T3	
T34	Observation 302 312	progresión
#30	AnnotatorNotes T34	C1457868; Worse; Finding (?)
R15	Overlap Arg1:T2 Arg2:T34	
R16	Overlap Arg1:T3 Arg2:T34	
R17	Before Arg1:T1 Arg2:T34	
R18	Before Arg1:T6 Arg2:T34	
R19	Experiences Arg1:T26 Arg2:T7	
R20	Experiences Arg1:T26 Arg2:T18	
R21	Experiences Arg1:T28 Arg2:T11	
R22	Causes Arg1:T13 Arg2:T33	
R23	Causes Arg1:T19 Arg2:T33	
R24	Causes Arg1:T15 Arg2:T33	
R25	Used_for Arg1:T13 Arg2:T14	
R26	Used_for Arg1:T19 Arg2:T14	
R27	Negation Arg1:T30 Arg2:T21	
R28	Used_for Arg1:T20 Arg2:T16	
R29	Before Arg1:T21 Arg2:T16	
R30	Experiences Arg1:T23 Arg2:T34	
R31	Experiences Arg1:T23 Arg2:T6	
R32	Experiences Arg1:T24 Arg2:T6	
R33	Experiences Arg1:T24 Arg2:T34	
A4	Experiencer T28 Patient
A5	Experiencer T27 Patient
A6	Experiencer T26 Patient
A7	Experiencer T23 Patient
A8	Experiencer T24 Patient
